// App-Quantinova.ai

: Cabozantinib in the elderly with metastatic renal cell carcinoma undergoing geriatric G8 screening test: A prospective multicenter observational study (ZEBRA/MEET-URO 9).

Researchers

Presenter

  • Umberto Basso

Principal Investigators

  • Elena Verzoni

  • Mariella Sorarù

  • Marilena Di Napoli

  • Lucia Fratino

  • Daniele Santini

  • Francesco Grillone

  • Vincenzo Emanuele Emanuele Chiuri

  • Claudia Carella

  • Francesco Atzori

  • Giandomenico Roviello

  • Donata Sartori

  • Marco Maruzzo

  • Francesco Pierantoni

  • Melissa Bersanelli

  • Melissa Ballestrin

  • Chiara De Toni

  • Alvise Mattana

  • Vittorina Zagonel

Medical Centers

  • Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy

  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy

  • Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy

  • Department of Oncology, Ospedale Vito Fazzi, Lecce, Italy

  • Department of Medical Oncology, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, Italy

  • Department of Medicine and Surgery, University of Salerno, Salerno, Italy

  • UOC Oncologia Medica Territoriale, La Sapienza University, Polo Pontino, Roma, Italy, Roma, Italy

  • U.O. Oncologia, Ospedale di Camposampiero (PD), Camposampiero (PD), Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Department of Cardiology, Ospedale Civile di Mirano, Mirano, Italy

  • Azienda Ospedaliero-Universitario "Mater Domini", Policlinico of Catanzaro, Catanzaro, Italy

  • Department of Oncology, University of Firenze, Firenze, Italy

  • Istituto Oncologico Giovanni Paolo II IRCCS, Bari, Italy

  • Department of Oncology, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Monserrato, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cabozantinib

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved